2026
AUGUST 2026: Congratulations to Chuda for her duo of papers published in JID Innovations on temporal outcomes of rituximab therapy of pemphigus vulgaris, as well as factors predictive of complete remission after rituximab therapy of pemphigus
JULY 2026: The Payne lab welcomes new Associate Research Scientist Hisashi Nomura, MD, PhD, and PhD student Alice Yi. Hisashi comes to Columbia from Keio University, where he studied the role of IgM to IgG class switch in development of the pemphigus phenotype and also developed functionally stabilized iTregs for antigen-specific immunosuppression for pemphigus. Alice graduated from the University of New Haven then trained in David Hafler’s laboratory at Yale studying the role of myeloid cells and regulatory T cells in autoimmune neurologic diseases. We also bid farewell and best wishes to Andrew Overmiller, PhD, who is starting a new position in Discovery Immunology at J&J.
FEBRUARY 2026: Congratulations to Farzan for his review on engineered cell therapies for autoimmunity, published in Nature Biotechnology
JANUARY 2026: The NIAID Autoimmunity Centers of Excellence ACV01 prospective clinical trial of COVID-19 booster vaccine responses in autoimmune disease individuals is published in JCI Insight
Lab shipping address:
Russ Berrie Medical Science Pavilion
1150 St. Nicholas Avenue
3rd Floor, Room 315
New York, NY 10032
212-851-4800
Clinical Office:
161 Fort Washington Avenue
12-1214 Herbert Irving Pavilion
New York, NY 10032
212-305-5665
